October 31, 2024
Emyria (ASX:EMD) partners with UWA for groundbreaking serotonin agents in mental health
Emyria’s exclusive licence with UWA marks a major advancement in mental health treatment, bringing innovative, safer serotonin-releasing agents closer to addressing critical needs in psychiatry and neurology.